Business
MGI ANNOUNCES PARTNERSHIP WITH NEGEDIA: ENHANCE GENOMIC SEQUENCING TECHNOLOGIES AT THE SERVICE OF SCIENTIFIC RESEARCH AND PRECISION MEDICINE IN ITALY
MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced a partnership with Negedia, an initiative born from Fondazione Telethon to expand access to DNBSEQ™-powered genomic sequencing and Stereo-seq spatial transcriptomics for precision medicine and biomedical research in Italy.
About this update from Mgi Tech Co., Ltd. Class A
[{"type":"list","items":[{"val":[{"type":"text","content":"In the study of rare diseases and precision medicine, understanding gene expression in the spatial context of tissues is essential. High-throughput sequencing and STOmics technology will enhance biological and molecular understanding of various pathologies.","length":267,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":267,"olType":false},{"type":"text","content":"MILAN, June 26, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced a partnership with Negedia, an initiative born from Fondazione Telethon to expand access to DNBSEQ™-powered genomic sequencing and Stereo-seq spatial transcriptomics for precision medicine and biomedical research in Italy.","length":418,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/MGI)","displaySize":"","headline":null,"caption":"(PRNewsfoto/MGI)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":252,"url":"https://media.zenfs.com/en/prnewswire.com/7536901334a49e87f77494392d80064d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/0Fyl0H4uEv.Pa7hcozlEew--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ0NDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/7536901334a49e87f77494392d80064d","width":400,"height":252}},"href":"https://mma.prnewswire.com/media/2329841/MGI__Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Negedia focuses on understanding an individual's genetic and molecular characteristics to make informed decisions about prevention, wellness and treatment. It is dedicated to researchers, specialists, and laboratories, offering innovative solutions that provide immediate answers for research and diagnostics.","length":358,"tagName":"p"},{"type":"text","content":"Under this collaboration, MGI will provide advanced DNBSEQ™ sequencing technology to expand Negedia's operational and analytical capacity for sample. Negedia has acquired MGI's DNBSEQ-T7 high-throughput sequencing platform, which enables high-resolution spatial transcriptomic analysis, allowing for the acquisition of the entire transcriptome-i.e., the RNA molecules transcribed from the genome—without compromisin...